Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates

Core Insights - Intellia Therapeutics, Inc. is a leading clinical-stage gene editing company focused on CRISPR-based therapies aimed at revolutionizing medicine [2] Group 1: Financial Results and Operational Highlights - Intellia will present its second quarter 2025 financial results and operational highlights on August 7, 2025, at 8 a.m. ET [1] - A replay of the conference call will be available on Intellia's website starting August 7, 2025, at 12 p.m. ET [1] Group 2: Company Overview - Intellia is dedicated to developing novel, first-in-class medicines that address significant unmet medical needs and advance treatment paradigms [2] - The company is expanding its CRISPR-based platform with novel editing and delivery technologies to harness the full potential of gene editing [2]